Literature DB >> 27062444

Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

Wenliang Zhang1, Qian Sun1,2, Wei Zhong1, Xinguo Sun1, Zhanxiang Zhou1,2.   

Abstract

BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPARγ) signaling has been shown to regulate lipogenesis and lipid accumulation. Previous studies have shown that hepatic PPARγ is up-regulated in steatotic liver of both animal and human. However, the effects of hepatic PPARγ signaling on alcoholic liver disease (ALD) remain elusive.
METHODS: To determine the role of hepatic PPARγ signaling on ALD, wild-type (WT) and hepatocyte-specific PPARγ knockdown (PPARγ∆Hep) mice were fed a modified Lieber-DeCarli alcohol or isocaloric maltose dextrin control liquid diet for 8 weeks to induce ALD. Blood parameters, hepatic steatosis, and inflammation were measured after 8-week alcohol feeding.
RESULTS: Alcohol feeding to WT mice resulted in liver damage (alanine aminotransferase [ALT], 94.68 ± 17.05 U/L; aspartate aminotransferase [AST], 55.87 ± 11.29 U/L), which was significantly alleviated by hepatic PPARγ knockdown (ALT, 57.36 ± 14.98 U/L; AST, 38.06 ± 3.35 U/L). Alcohol feeding led to marked lipid accumulation and up-regulation of lipogenic genes including fatty acid transport protein 1 (FATP1), acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN), lipin1 (LIPIN1), diacylglycerol acyltransferase 1 (DGAT1), and diacylglycerol acyltransferase 2 (DGAT2) in the livers of WT mice. Knockdown of hepatic PPARγ significantly alleviated alcohol-induced lipid accumulation and abolished the up-regulation of FASN, DGAT1, and DGAT2. Silencing of PPARγ in FL83B cells significantly decreased ethanol (EtOH)-, linoleic acid-, and EtOH plus linoleic acid-induced lipid accumulation. Knockdown of hepatic PPARγ also significantly reduced alcohol-induced inflammatory chemokine (monocyte chemotactic protein 1 [MCP1], keratinocyte-derived chemokine [KC], interferon gamma-induced protein 10 [IP-10]) and inflammatory infiltration (lymphocyte antigen 6 complex, locus G [Ly6G], and F4/80).
CONCLUSIONS: The results suggest that hepatic PPARγ signaling contributes to alcohol-induced liver injury by promoting hepatic steatosis and inflammation.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcoholic Liver Disease; Hepatic Inflammation; Hepatic Lipogenesis; Peroxisome Proliferator-Activated Receptor Gamma

Mesh:

Substances:

Year:  2016        PMID: 27062444      PMCID: PMC5742869          DOI: 10.1111/acer.13049

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  53 in total

1.  How to do successful gene expression analysis using real-time PCR.

Authors:  Stefaan Derveaux; Jo Vandesompele; Jan Hellemans
Journal:  Methods       Date:  2009-12-05       Impact factor: 3.608

2.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

Authors:  S J Smith; S Cases; D R Jensen; H C Chen; E Sande; B Tow; D A Sanan; J Raber; R H Eckel; R V Farese
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Sex differences in PPARgamma expressions in rat adipose tissues.

Authors:  Kyoko Kadowaki; Katsumi Fukino; Etsuko Negishi; Koichi Ueno
Journal:  Biol Pharm Bull       Date:  2007-04       Impact factor: 2.233

4.  Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis.

Authors:  Wei Zhong; Yantao Zhao; Yunan Tang; Xiaoli Wei; Xue Shi; Wenlong Sun; Xiuhua Sun; Xinmin Yin; Xinguo Sun; Seongho Kim; Craig J McClain; Xiang Zhang; Zhanxiang Zhou
Journal:  Am J Pathol       Date:  2012-01-09       Impact factor: 4.307

Review 5.  Advances in alcoholic liver disease.

Authors:  Juliane I Beier; Gavin E Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2011-02

6.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

7.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

Authors:  Susan E Schadinger; Nancy L R Bucher; Barbara M Schreiber; Stephen R Farmer
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01-11       Impact factor: 4.310

9.  A meta-analysis of alcohol consumption and the risk of 15 diseases.

Authors:  Giovanni Corrao; Vincenzo Bagnardi; Antonella Zambon; Carlo La Vecchia
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

10.  IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.

Authors:  Thomas Reiberger; Judith H Aberle; Michael Kundi; Norbert Kohrgruber; Armin Rieger; Alfred Gangl; Heidemarie Holzmann; Markus Peck-Radosavljevic
Journal:  Antivir Ther       Date:  2008
View more
  19 in total

Review 1.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

Review 2.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

3.  Inflammation is independent of steatosis in a murine model of steatohepatitis.

Authors:  Wei Wang; Ming-Jiang Xu; Yan Cai; Zhou Zhou; Haixia Cao; Partha Mukhopadhyay; Pal Pacher; Shusen Zheng; Frank J Gonzalez; Bin Gao
Journal:  Hepatology       Date:  2017-05-18       Impact factor: 17.425

Review 4.  Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice.

Authors:  Afroza Ferdouse; Robin D Clugston
Journal:  Front Physiol       Date:  2022-07-05       Impact factor: 4.755

5.  Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease.

Authors:  Fei Zhao; Jun Chen; Rui Guo; Jinyan Zhu; Weijia Gu; Songtao Li; Jiaomei Li
Journal:  Nutr Metab (Lond)       Date:  2022-07-05       Impact factor: 4.654

6.  Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis.

Authors:  Jeongeun Hyun; Zhaoli Sun; Ali Reza Ahmadi; Sushant Bangru; Ullas V Chembazhi; Kuo Du; Tianyi Chen; Hidekazu Tsukamoto; Ivan Rusyn; Auinash Kalsotra; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

7.  Adipose-specific lipin1 overexpression in mice protects against alcohol-induced liver injury.

Authors:  Wenliang Zhang; Wei Zhong; Qian Sun; Xinguo Sun; Zhanxiang Zhou
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

Review 8.  Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame.

Authors:  Pierluigi Ramadori; Francisco Javier Cubero; Christian Liedtke; Christian Trautwein; Yulia A Nevzorova
Journal:  Cancers (Basel)       Date:  2017-09-25       Impact factor: 6.639

9.  Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse.

Authors:  Stephanie K Meyer; Philip M E Probert; Anne F Lakey; Andrew R Axon; Alistair C Leitch; Faith M Williams; Paul A Jowsey; Peter G Blain; George E N Kass; Matthew C Wright
Journal:  Toxicol Lett       Date:  2017-03-27       Impact factor: 4.372

10.  The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation.

Authors:  J Chen; Y Liu; S Lu; L Yin; C Zong; S Cui; D Qin; Y Yang; Q Guan; X Li; X Wang
Journal:  Int J Obes (Lond)       Date:  2016-10-26       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.